Abstract
Objective: The global burden of colorectal cancer (CRC) is expected to increase by 60% to more than 2.2 million new cases and 1.1 million deaths by 2030. In this study, we aim to describe the recent CRC incidence and mortality patterns and trends linking the findings to the prospects of reducing the burden through cancer prevention and care.
Design: Estimates of sex-specific CRC incidence and mortality rates in 2012 were extracted from the GLOBOCAN database. Temporal patterns were assessed for 37 countries using data from Cancer Incidence in Five Continents (CI5) volumes I-X and the WHO mortality database. Trends were assessed via the annual percentage change using joinpoint regression and discussed in relation to human development levels.
Results: CRC incidence and mortality rates vary up to 10-fold worldwide, with distinct gradients across human development levels, pointing towards widening disparities and an increasing burden in countries in transition. Generally, CRC incidence and mortality rates are still rising rapidly in many low-income and middle-income countries; stabilising or decreasing trends tend to be seen in highly developed countries where rates remain among the highest in the world.
Conclusions: Patterns and trends in CRC incidence and mortality correlate with present human development levels and their incremental changes might reflect the adoption of more western lifestyles. Targeted resource-dependent interventions, including primary prevention in low-income, supplemented with early detection in high-income settings, are needed to reduce the number of patients with CRC in future decades.
Keywords: COLORECTAL CANCER; EPIDEMIOLOGY.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Similar articles
-
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.PMID: 33538338
-
International variations and trends in testicular cancer incidence and mortality.Eur Urol. 2014 Jun;65(6):1095-106. doi: 10.1016/j.eururo.2013.11.004. Epub 2013 Nov 14.PMID: 24268506
-
International variations in bladder cancer incidence and mortality.Eur Urol. 2014 Jul;66(1):59-73. doi: 10.1016/j.eururo.2013.10.001. Epub 2013 Oct 16.PMID: 24451595
-
International variations and trends in renal cell carcinoma incidence and mortality.Eur Urol. 2015 Mar;67(3):519-30. doi: 10.1016/j.eururo.2014.10.002. Epub 2014 Oct 16.PMID: 25449206 Review.
-
Worldwide variations in colorectal cancer.CA Cancer J Clin. 2009 Nov-Dec;59(6):366-78. doi: 10.3322/caac.20038.PMID: 19897840 Review.
Cited by
-
Effect of diabetes mellitus type 2 and sulfonylurea on colorectal cancer development: a case-control study.BMC Gastroenterol. 2024 Oct 28;24(1):382. doi: 10.1186/s12876-024-03477-4.PMID: 39465354 Free PMC article.
-
CXCL11 Correlates With Antitumor Immunity and an Improved Prognosis in Colon Cancer.Front Cell Dev Biol. 2021 Mar 11;9:646252. doi: 10.3389/fcell.2021.646252. eCollection 2021.PMID: 33777950 Free PMC article.
-
Emerging roles for IL-25 and IL-33 in colorectal cancer tumorigenesis.Front Immunol. 2022 Oct 3;13:981479. doi: 10.3389/fimmu.2022.981479. eCollection 2022.PMID: 36263033 Free PMC article. Review.
-
Long non-coding RNA KCNQ1OT1 up-regulates CTNND1 by sponging miR-329-3p to induce the proliferation, migration, invasion, and inhibit apoptosis of colorectal cancer cells.Cancer Cell Int. 2020 Jul 24;20:340. doi: 10.1186/s12935-020-01425-2. eCollection 2020.PMID: 32760218 Free PMC article.
-
Two novel qualitative transcriptional signatures robustly applicable to non-research-oriented colorectal cancer samples with low-quality RNA.J Cell Mol Med. 2021 Apr;25(7):3622-3633. doi: 10.1111/jcmm.16467. Epub 2021 Mar 14.PMID: 33719152 Free PMC article.


